Aggregate
This presentation is the property of its rightful owner.
Sponsored Links
1 / 27

Aggregate Spend Pre-Disclosure, Certification, and Disputes Management Survey Results April 3 , 2014 PowerPoint PPT Presentation


  • 90 Views
  • Uploaded on
  • Presentation posted in: General

Aggregate Spend Pre-Disclosure, Certification, and Disputes Management Survey Results April 3 , 2014. Introduction. Today’s Speakers. LEANNE DIDOMENICO I Philadelphia, PA Manager with 13 years of experience working with global life sciences companies

Download Presentation

Aggregate Spend Pre-Disclosure, Certification, and Disputes Management Survey Results April 3 , 2014

An Image/Link below is provided (as is) to download presentation

Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author.While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server.


- - - - - - - - - - - - - - - - - - - - - - - - - - E N D - - - - - - - - - - - - - - - - - - - - - - - - - -

Presentation Transcript


Aggregate spend pre disclosure certification and disputes management survey results april 3 2014

Aggregate Spend Pre-Disclosure, Certification, and Disputes Management Survey ResultsApril 3, 2014


Introduction

Introduction

Today’s Speakers

  • LEANNE DIDOMENICO I Philadelphia, PA

  • Manager with 13 years of experience working with global life sciences companies

  • Current focus is assisting companies to address behavioral change across their organization and the supporting tactics needed to make a business transformation successful, including a special focus on transformation required from regulations and compliance driven initiatives

  • Recent accomplishments include developing and executing a comprehensive change management strategy for a global pharmaceutical company with several affiliate businesses; aligned businesses, vendors and employees to a single process for accurate spend data capture; included development of a disciplinary model

  • JOSEPH MORRELL I Washington DC

  • Manager with 10 years of experience working with global life sciences companies

  • Current focus is working with pharmaceutical and medical device clients to identify and address compliance issues related to state and federal aggregate spend reporting, off-label monitoring, & government-mandated needs assessments

  • Recent accomplishments include assisting a top 5 global manufacturer with operational issues related to clinical data transparency; including implementing systems and processes to create greater efficiencies across the organization


Agenda

Agenda

Today, we hope to provide insights into Huron’s 2014 Aggregate Spend Pre-Disclosure, Certification, and HCP Dispute Survey.

Specifically, the agenda is comprised of the following:

Closing remarks: Long Term Strategies To Mitigate Risk And Improve Operations

Survey OVERVIEW & METHODOLOGY

REPORTING OPERATIONS

INTERNAL CERTIFICATIONS

PRE-DISCLOSURE PRACTICES

PREPARING FOR INQUIRIES & DISPUTES


Why survey now

Why Survey Now?

Benchmarking Drivers:

#1 factor was to respond to client demand; through our own experience working with clients we were seeing common struggles and themes

Our intent was to provide real insights and data to support our clients when they make decisions across the industry as they prepare for Open Payments disclosure

Our goal is to continue to provide “quick” benchmarking as a service


Survey overview and methodology

Survey Overview and Methodology


Survey overview and methodology1

Survey Overview and Methodology

  • Huron Life Sciences surveyed 38 life science companies in the first quarter of 2014.

  • We asked respondents to answer questions about their aggregate spend program across five primary areas:

  • Company Revenue / Industry

  • Reporting Operations: Organization, Personnel, Expected Volume

  • Internal Certification: Frequency and Methodology

  • Pre-Disclosure

  • Dispute Readiness: System, Process, and Sales Involvement


Survey overview and methodology2

Survey Overview and Methodology

  • Responses were received from 38 companies; respondents crossed both pharmaceutical and medical device manufacturers and were of a variety of sizes:


Discussion of detailed results

Discussion of Detailed Results


Detailed results reporting operations

Detailed Results: Reporting Operations

The number of Covered Recipients (CRs) each company expects to report on increases dramatically with company size.


Detailed results reporting operations1

Detailed Results: Reporting Operations

The number of employees dedicated to reporting increases with size.

There is a great deal of variation within each size group and no direct correlation with expected number of covered recipients.


Detailed results reporting operations2

Detailed Results: Reporting Operations

Responsibility for transparency reporting continues to typically reside with Compliance:


Detailed results internal certification

Detailed Results: Internal Certification

73% of respondents indicated that business units outside of the core aggregate spend function will review data prior to reporting. Of those conducting an internal review, only 5 (out of 22) were required to do so by CIA obligations.


Considerations internal certification

Considerations: Internal Certification

When setting up a program for internal certifications, companies need to consider:

  • If employees from the core reporting functions will be assigned to be “relationship owners” with certain business areas.

  • Whether or not a live review will be conducted with senior business leadership.

  • The scope of transactions that will be reviewed (e.g. if T&E transactions have already been reviewed by line management, do they need to be re-reviewed?)

  • Dashboard-style trend reporting that may be useful for senior leadership.


Detailed results internal certification1

Detailed Results: Internal Certification

Four out of five respondents rely on a manual process to complete their internal certification.

Typically, only one level of review is completed. Over 40% of respondents complete at least a second level of review beyond that.


Detailed results pre disclosure practices

Detailed Results: Pre-Disclosure Practices

Only 30% of respondents currently have firm plans to pre-disclose transparency data; another third have plans not to pre-disclose, and the remainder are still undecided.


Considerations pre disclosure practices

Considerations: Pre-Disclosure Practices

For those companies undecided on their approach to pre-disclosure, consider…

  • Would business or R&D functions support a limited pre-disclosure to customers with a higher volume of transactions, or total transactions over a certain dollar amount?

  • Will pre-disclosure potentially reduce the workload on your team during the CMS inquiry and dispute period?

  • How will the company respond to requests that may be received from teaching hospitals for a comprehensive pre-disclosure report?

    The additional time now available before the line-item report is due to CMS may offer your company an opportunity to “pressure test” its dispute systems and processes prior to the formal CMS dispute window.


Detailed results preparing for inquiries disputes

Detailed Results: Preparing for Inquiries & Disputes

Only 12% of respondents have fully implemented a technological solution for managing HCP inquiries and disputes

However, around half of all respondents have a documented process in place


Considerations preparing for inquiries disputes

Considerations: Preparing for Inquiries & Disputes

When preparing for inquiries & disputes, consider…

  • Have all potential sources of inquiries (call centers, adverse event reporting area, sales representative help desk) been identified? Are they equipped to at least document inquiries or disputes that may come in outside of the CMS framework? Where will incoming calls from the media, lawyers, the public, and other sources be routed to?

  • Have FAQs or key talking points been developed and approved?

  • Should HCPs that dispute a transaction this year automatically be added to your company’s pre-disclosure list for next year?

  • How can you track and identify potential “dispute themes” (research related, regional, etc.)?

  • How will the company manage inquiries for transactions that may not have detailed documentation (educational items, meals, etc.)?


Detailed results preparing for inquiries disputes1

Detailed Results: Preparing for Inquiries & Disputes

Respondents have typically allocated one or two resources to manage HCP inquiries & disputes and typically expect less than 5% of transactions to be disputed.


Detailed results preparing for inquiries disputes2

Detailed Results: Preparing for Inquiries & Disputes

Most respondents have indicated they expect relatively little involvement from the sales force in resolving HCP disputes.


Long term strategies to mitigate risk improve operations

Long Term Strategies To Mitigate Risk & Improve Operations


Steps you can take today assess high risk areas

Steps You Can Take Today - Assess High Risk Areas

  • Aggregate spend data, combined with other internal data sources, can help identify areas of risk across different parts of your company’s operations, for example:


Implement monitoring tools for real time risk tracking

Implement Monitoring Tools For Real Time Risk Tracking

HCP Not Contracted Prior to Services

Meals Above per HCP Meal Limit

Policy Limit ($)

Timeliness

HCP Spend ($)

δ

“Rep A reported over HCP meal limit ($7)”

Inappropriate HCP Spend (e.g., entertainment)

Irreconcilable Sampling Inventories

Track Sampling Outliers

Spending Patterns

Grants

Travel

Entertainment


Leveraging open payments data to add value building sustainable compliance operations

Leveraging Open Payments Data to Add ValueBuilding Sustainable Compliance Operations

How can your team leverage available data to bring value to the rest of the company?

With Procurement: Identify total company-wide spend per vendor

With Sales Operations: Establish total spending on, for example, meals compared to competitor spending levels

With Clinical Ops: Compare per-subject spending with per-subject spending of peer companies (based on Aggregate Spend and ClinicalTrials.gov data)

With Sales Leadership: In conjunction with other publically available data, identify other key opinion leaders that may not have been considered by your company before


Challenges facing our industry today future surveying

Challenges Facing Our Industry Today & Future Surveying

SHORT TERM HURDLES:

Setting up sustainable processes to capture external vendor’s spend data

Research Payments

Data Verification and Proactive Risk Mitigation

  • LONG TERM HURDLES:

  • Alignment of compliance and transparency processes across continents to meet the demands of a global healthcare and regulatory environment.

  • Maintaining valuable KOL relationships to support research and innovation.

We want to hear

from you!

Submit your benchmarking ideas to [email protected]

by April 30 to be considered for our next benchmarking analysis.


Thank you and contact us

Thank You and Contact Us

Thank you to all the organizations who participated in Huron’s Benchmarking Survey. Your input is greatly valued, and provides critical benchmarking data for establishing best practices in an ever-changing regulatory landscape.

Please feel free to reach out to us if you have questions about the survey or if you have additional items you would like to see in 2014.

Speaker Contact Information:

Joseph Morrell, Manager

Phone: 312.731.7469

Email: [email protected]

For Consultation Services Contact:

Manny Tzavlakis, Managing Director

Phone: 312.532.1504

Email: [email protected]

Leanne DiDomenico, Manager

Phone: 267.250.9434

Email: [email protected]


  • Login